Raf蛋白激酶与细胞信号传导

Ras蛋白信号通路的信号传递蛋白Raf-1蛋白激酶,不仅在该通路中起重要作用,也能整合PKC的信号。Raf-1蛋白激酶活化后参与细胞增殖和转化、细胞编程死亡、发育和分化,以及细胞对不良因素的应激反应,是细胞内重要的、进化上十分保守的信号分子。     

植物蛋白激酶与作物非生物胁迫抗性的研究

干旱、盐碱、高温等非生物逆境胁迫严重影响作物生长发育、产量和品质。在遭受非生物逆境的威胁时,植物通过信号受体,可感知、转导胁迫信号,启动一系列抗逆相关基因的表达,最终缓解或抵御非生物逆境胁迫对植物造成的危害。其中,蛋白激酶和蛋白磷酸酯酶的磷酸化/去磷酸化作用在植物感受外界胁迫信号的分子传递过程中起到开关的作用。正常情况下,蛋白激酶磷酸化开启信号转导途径,启动相应的抗逆基因表达反应;当信号消失后,蛋白激酶去磷酸化将信号转导途径关闭,达到调控植物正常生长的目的。因此,蛋白激酶在调控感受胁迫信号、启动各种非生物逆境胁迫响应中起到了极其重要的作用。近年来,对植物蛋白激酶参与非生物胁迫响应的研究倍受关注。本文阐述了不同类型蛋白激酶在改良作物非生物胁迫抗性上的应用,为进一步研究提供资料。     

磷脂酰乙醇胺结合蛋白的基础和临床研究

磷脂酰乙醇胺结合蛋白 ( phosphatidylethanolamine-binding protein, PEBP )是一类高度保守的多功能蛋白质,广泛存在于不同物种中.在同一物种的多种组织和不同类型细胞中均有表达.PEBP在多条信号转导通路中具有重要的调控作用.PEBP通过与Raf-1相互作用抑制MAPK信号通路的活性,因此也被称为Raf-1激酶抑制蛋白(RKIP);同时,PEBP还参与了PKC、G蛋白偶联受体和NF-κB信号通路的调控.在临床医学研究中发现,PEBP作为海马胆碱神经刺激肽(HCNP)的前体蛋白在阿尔采末病(AD)的形成过程中发挥重要作用.由于PEBP可以抑制肿瘤转移和促进肿瘤细胞凋亡,因此也被认为是一种肿瘤转移的抑制基因.新近研究表明,PEBP参与细胞周期的纺锤体检查点的调控,PEBP的缺失可导致染色体异常.在直肠结肠癌,PEBP基因启动子区的高甲基化可导致其不表达,这可能是癌症转移的分子基础.     

巨噬细胞免疫调变信号——Raf-1,MAPK,cPLA2的激活和IL-12分泌的研究

LPS介导的小鼠腹腔巨噬细胞免疫调变的信号和机理是不清楚的.应用LPS和PMA处理抑制性巨噬细胞后,发现Ras下游信号分子Raf-1,MAPK和cPLA₂均被活化,包括Raf-1的磷酸化,MAPK p44和p42磷酸化以及cPLA_2的活化,使花生四烯酸的释放显著增加,结合新近发现的LPS、PMA能诱导抑制性巨噬细胞PKC-α和PKC-ε同工酶的激活与转位,认为在LPS介导的免疫调变中,PKC信号通路的活化及其与Raf-1/MAPK通路的“连接”是主要信号传导通路.同时调变巨噬细胞也能分泌IL-12.     

大鼠高血压相关基因表达蛋白抑制血管平滑肌细胞增殖

大鼠高血压相关基因 ( r HRG- 1 )编码一新细胞内信号传递蛋白 .体外转染 r HRG- 1表达蛋白发现 r HRG- 1表达蛋白能抑制自发性高血压大鼠血管平滑肌细胞内 Raf蛋白 ( Raf- 1 )和丝裂素活化蛋白激酶 ( MAPK)活性 ,抑制抗细胞凋亡基因 ( bcl- 2 )和增殖细胞核抗原 ( PCNA)基因 m RNA表达 ,同时还抑制该细胞 DNA的合成 .r HRG- 1是一正常血压大鼠血管平滑肌细胞内高度表达的基因 ,由此推测在自发性高血压大鼠血管平滑肌细胞内转染 r HRG- 1表达蛋白抑制其细胞 DNA合成的作用可能是抑制细胞内 Raf- 1活性与 MAPK活性及抑制 PCNA和 bcl- 2基因表达的结果     

生长因子受体酪氨酸激酶的结构与功能

受体酪氨酸蛋白激酶是细胞信号转导进行的关键信号酶,在生长因子调控细胞生长、发育与功能的过程中起着重要的生理作用.本文主要介绍生长因子受体酪氨酸蛋白激酶的分类、结构与功能及其部分相关信号转导机制的研究进展.     

丛枝菌根共生的信号转导及其相关基因

大多数植物根系能够与某些真菌形成相互依存、互惠互利的菌根共生关系.植物在提供给丛枝菌根真菌赖以生存的碳源的同时,也通过真菌从土壤中吸取矿质营养.丛枝菌根能够促进植物生长,提高植物抗逆性和抵御外界不良环境,对提高农林业生产效率、增强生态系统稳定性及维护生物多样性具有重要的意义.菌根的形成是一系列信号分子交换传递和共生相关基因表达调控的结果.在信号转导途径中,共生受体样蛋白激酶、离子通道和钙/钙调依赖性蛋白激酶基因的表达对菌根的形成是不可或缺的.就丛枝菌根共生的信号转导机制以及信号途径中3个必需基因的结构、功能及研究现状进行了综述.     

植物富含亮氨酸重复序列型类受体蛋白激酶的生物学功能

介绍了植物富含亮氨酸重复序列(leucine-rich repeat,LRR)型类受体蛋白激酶概念、最近发现的这类蛋白激酶的亚结构域特征;总结了目前已确定其功能的LRR型类受体蛋白激酶,并分别阐述了它们在参与植物抗逆性反应、发育调控及激素的信号转导等过程中的生物学功能;着重介绍和讨论了LRR型类受体蛋白激酶复合物之间及其与下游成分KAPP之间互作而产生信号传递的分子机理.最后展望了LRR型类受体蛋白激酶生物学功能、信号转导机制、以及应用于生产实践的研究前景.     

ABA信号转导途径中的MAPKs

脱落酸（ABA）是植物体内一种重要的激素分子,在调节植物生长发育和对环境适应的过程中发挥重要的信号作用。促分裂原活化蛋白激酶（MAPK）是一种广泛存在于真核生物中的信号转导途径,由环境胁迫、细胞因子、植物激素、生长因子等诱导,是植物细胞信号转导过程中的主要级联途径之一。已知许多蛋白激酶和蛋白磷酸酶参与了ABA信号途径,MAPKs作为ABA信号转导的下游组分发挥着重要的调节作用。本文就MAPK级联参与ABA信号转导途径的相关研究进展进行叙述,以便对MAPKs和ABA信号之间的交互作用（cross-talk）机制有更深入了解。     

活性氧信号传导作用的研究进展

活性氧的信号传导作用已经为大量研究结果所证实,氧化还原修饰靶分子是其信号传导的主要机制.活性氧的信号传导作用几乎与所有已知的信号传导途径相关,蛋白酪氨酸激酶、蛋白激酶C、分裂刺激因子激活的蛋白激酶、转录因子NF-κB、AP-1及Ca^2＋、环鸟酸苷等信号分子都参与活性氧的信号传导作用.但是,有关活性氧信号传导作用还有许多问题有待阐明.     

Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase

The Ras-Raf-mitogen-activated protein kinase cascade is a key growth-signaling pathway, which uncontrolled activation results in transformation. Although the exact mechanisms underlying Raf-1 regulation remain incompletely understood, phosphorylation has been proposed to play a critical role in this regulation. We report here three novel epidermal growth factor-induced in vivo Raf-1 phosphorylation sites that mediate positive feedback Raf-1 regulation. Using mass spectrometry, we identified Raf-1 phosphorylation on three SP motif sites: S289/S296/S301 and confirmed their identity using two-dimensional-phosphopeptide mapping and phosphospecific antibodies. These sites were phosphorylated by extracellular signal-regulated kinase (ERK)-1 in vitro, and their phosphorylation in vivo was dependent on endogenous ERK activity. Functionally, ERK-1 expression sustains Raf-1 activation in a manner dependent on Raf-1 phosphorylation on the identified sites, and S289/296/301A substitution markedly decreases the in vivo activity of Raf-1 S259A. Importantly, the ERK-phosphorylated Raf-1 pool has 4 times higher specific kinase activity than total Raf-1, and its phosphopeptide composition is similar to that of the general Raf-1 population, suggesting that the preexisting, phosphorylated Raf-1, representing the activatable Raf-1 pool, is the Raf-1 subpopulation targeted by ERK. Our study describes the identification of new in vivo Raf-1 phosphorylation sites targeted by ERK and provides a novel mechanism for a positive feedback Raf-1 regulation.     

Taming the Hippo: Raf-1 Controls Apoptosis by Suppressing MST2/Hippo

The Raf-1 kinase has a well established role in activating the MEK-ERK/MAPK pathway.However, accumulating evidence including the phenotype of Raf-1-/- mice suggested thatRaf-1 may have other functions independent of its role as MEK activator, in particularpertaining to protection against apoptosis. We have recently demonstrated a new role of Raf-1 by showing that Raf-1 controls the proapoptotic kinase MST2/Hippo. In mammalian cellsMST2 is activated by stress signals and causes apoptosis when overexpressed. Its Drosophilahomologue Hippo regulates apoptosis and cell cycle arrest during differentiation. Raf-1inhibits MST2 by preventing its dimerisation and recruiting a phosphatase that removesactivating phosphorylations on MST2. Both functions require Raf-1 binding to MST2, butare independent of Raf-1’s kinase activity and the ERK pathway. Downregulation of MST2by siRNA reverts the apoptosis hypersensitivity of Raf-1-/- mouse fibroblasts. In contrast, thedownregulation of Raf-1 in Raf-1+/+ cells and human cancer cell lines enhances susceptibilityto Fas induced apoptosis, which is rescued by concomitant downregulation of both Raf-1 andMST2. The MST2:Raf-1 complex is dissociated by stress signals as well as mitogens. Stresssignals robustly activate MST2 and trigger apoptosis. Mitogens only make MST2 permissivefor activation by releasing it from Raf-1, and in addition activate survival pathways allowingproliferation. Thus, by linking mitogenic and apoptotic signalling the MST:Raf-1 complexmay serve as a safeguard against unlicensed proliferation.     

Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CD3-stimulated primary human T cells.

To gain further insight into the role of Raf-1 in normal cell growth, c-raf-1 mRNA expression, Raf-1 protein production, and Raf-1-associated kinase activity in normal human T cells were analyzed. In contrast to the constitutive expression of Raf-1 in continuously proliferating cell lines, c-raf-1 mRNA and Raf-1 protein levels were barely detectable in freshly isolated G0 T lymphocytes. Previous work with fibroblasts has suggested that Raf-1 plays a signaling role in the G0-G1 phase transition. In T cells, triggering via the T-cell antigen receptor (TCR)-CD3 complex (TCR/CD3) resulted in an approximately fourfold increase in c-raf-1 mRNA. In addition, the promotion of G1 progression by interleukin 2 (IL-2) was associated with a 5- to 10-fold immediate/early induction of c-raf-1 mRNA, resulting in up to a 12-fold increase in Raf-1 protein expression. TCR/CD3 activation did not alter the phosphorylation state of Raf-1, whereas interleukin 2 receptor stimulation resulted in a rapid increase in the phosphorylation state of a subpopulation of Raf-1 molecules progressively increasing throughout G1. These findings were complemented by assays for Raf-1-associated kinase activity which revealed a gradual accumulation of serine and threonine autokinase activity in Raf-1 immunoprecipitates during G1, which remained elevated throughout DNA replication.     

The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments.

Using immobilized GST-Raf-1 as bait, we have isolated the intermediate filament protein vimentin as a Raf-1-associated protein. Vimentin coimmunoprecipitated and colocalized with Raf-1 in fibroblasts. Vimentin was not a Raf-1 substrate, but was phosphorylated by Raf-1-associated vimentin kinases. We provide evidence for at least two Raf-1-associated vimentin kinases and identified one as casein kinase 2. They are regulated by Raf-1, since the activation status of Raf-1 correlated with the phosphorylation of vimentin. Vimentin phosphorylation by Raf-1 preparations interfered with its polymerization in vitro. A subset of tryptic vimentin phosphopeptides induced by Raf-1 in vitro matched the vimentin phosphopeptides isolated from v-raf-transfected cells labeled with orthophosphoric acid, indicating that Raf-1 also induces vimentin phosphorylation in intact cells. In NIH 3T3 fibroblasts, the selective activation of an estrogen-regulated Raf-1 mutant induced a rearrangement and depolymerization of the reticular vimentin scaffold similar to the changes elicited by serum treatment. The rearrangement of the vimentin network occurred independently of the MEK/ERK pathway. These data identify a new branch point in Raf-1 signaling, which links Raf-1 to changes in the cytoskeletal architecture.     

p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association

Raf-1 protects cells from apoptosis, independently of its signals to MEK and ERK, by translocating to the mitochondria where it binds Bcl-2 and displaces BAD. However, the answer to the question of how Raf-1 is normally lured to the mitochondria and becomes activated remains elusive. p21-activated protein kinases (Paks) are serine/threonine protein kinases that phosphorylate Raf-1 at Ser-338 and Ser-339. Here we elucidate the molecular mechanism through which Pak1 signals to BAD through a Raf-1-activated pathway. Upon phosphorylation by Pak1, Raf-1 translocates to mitochondria and phosphorylates BAD at Ser-112. Moreover, the mitochondrial translocation of Raf-1 and the interaction between Raf-1 and Bcl-2 are regulated by Raf-1 phosphorylation at Ser-338/Ser-339. Notably, we show that formation of a Raf-1-Bcl-2 complex coincides with loss of an interaction between Bcl-2 and BAD. These signals are specific for Pak1, because Src-activated Raf-1 only stimulates the MAP kinase cascade. Thus, our data identify the molecular connections of a Pak1-Raf-1-BAD pathway that is involved in cell survival signaling.     

Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro.

The serine/threonine kinase Raf-1 functions downstream from Ras to activate mitogen-activated protein kinase kinase, but the mechanisms of Raf-1 activation are incompletely understood. To dissect these mechanisms, wild-type and mutant Raf-1 proteins were studied in an in vitro system with purified plasma membranes from v-Ras- and v-Src-transformed cells (transformed membranes). Wild-type (His)6- and FLAG-Raf-1 were activated in a Ras- and ATP-dependent manner by transformed membranes; however, Raf-1 proteins that are kinase defective (K375M), that lack an in vivo site(s) of regulatory tyrosine (YY340/341FF) or constitutive serine (S621A) phosphorylation, that do not bind Ras (R89L), or that lack an intact zinc finger (CC165/168SS) were not. Raf-1 proteins lacking putative regulatory sites for an unidentified kinase (S259A) or protein kinase C (S499A) were activated but with apparently reduced efficiency. The kinase(s) responsible for activation by Ras or Src may reside in the plasma membrane, since GTP loading of plasma membranes from quiescent NIH 3T3 cells (parental membranes) induced de novo capacity to activate Raf-1. Wild-type Raf-1, possessing only basal activity, was not activated by parental membranes in the absence of GTP loading. In contrast, Raf-1 Y340D, possessing significant activity, was, surprisingly, stimulated by parental membranes in a Ras-independent manner. The results suggest that activation of Raf-1 by phosphorylation may be permissive for further modulation by another membrane factor, such as a lipid. A factor(s) extracted with methanol-chloroform from transformed membranes or membranes from Sf9 cells coexpressing Ras and SrcY527F significantly enhanced the activity of Raf-1 Y340D or active Raf-1 but not that of inactive Raf-1. Our findings suggest a model for activation of Raf-1, wherein (i) Raf-1 associates with Ras-GTP, (ii) Raf-1 is activated by tyrosine and/or serine phosphorylation, and (iii) Raf-1 activity is further increased by a membrane cofactor.     

Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro.

Raf-1 is a serine/threonine kinase which is essential in cell growth and differentiation. Tyrosine kinase oncogenes and receptors and p21ras can activate Raf-1, and recent studies have suggested that Raf-1 functions upstream of MEK (MAP/ERK kinase), which phosphorylates and activates ERK. To determine whether or not Raf-1 directly activates MEK, we developed an in vitro assay with purified recombinant proteins. Epitope-tagged versions of Raf-1 and MEK and kinase-inactive mutants of each protein were expressed in Sf9 cells, and ERK1 was purified as a glutathione S-transferase fusion protein from bacteria. Raf-1 purified from Sf9 cells which had been coinfected with v-src or v-ras was able to phosphorylate kinase-active and kinase-inactive MEK. A kinase-inactive version of Raf-1 purified from cells that had been coinfected with v-src or v-ras was not able to phosphorylate MEK. Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1. We conclude that MEK is a direct substrate of Raf-1 and that the activation of MEK by Raf-1 is due to phosphorylation by Raf-1, which is sufficient for MEK activation. We also tested the ability of protein kinase C to activate Raf-1 and found that, although protein kinase C phosphorylation of Raf-1 was able to stimulate its autokinase activity, it did not stimulate its ability to phosphorylate MEK.     

Raf-1 levels determine the migration rate of primary endometrial stromal cells of patients with endometriosis

Endometriosis is a disease characterized by the localization of endometrial tissue outside the uterine cavity. The differences observed in migration of human endometrial stromal cells (hESC) obtained from patients with endometriosis versus healthy controls were proposed to correlate with the abnormal activation of Raf-1/ROCKII signalling pathway. To evaluate the mechanism by which Raf-1 regulates cytoskeleton reorganization and motility, we used primary eutopic (Eu-, n = 16) and ectopic (Ec-, n = 8; isolated from ovarian cysts) hESC of patients with endometriosis and endometriosis-free controls (Co-hESC, n = 14). Raf-1 siRNA knockdown in Co- and Eu-hESC resulted in contraction and decreased migration versus siRNA controls. This phenotype was reversed following the re-expression of Raf-1 in these cells. Lowest Raf-1 levels in Ec-hESC were associated with hyperactivated ROCKII and ezrin/radixin/moesin (E/R/M), impaired migration and a contracted phenotype similar to Raf-1 knockdown in Co- and Eu-hESC. We further show that the mechanism by which Raf-1 mediates migration in hESC includes direct myosin light chain phosphatase (MYPT1) phosphorylation and regulation of the levels of E/R/M, paxillin, MYPT1 and myosin light chain (MLC) phosphorylation indirectly via the hyperactivation of ROCKII kinase. Furthermore, we suggest that in contrast to Co-and Eu-hESC, where the cellular Raf-1 levels regulate the rate of migration, the low cellular Raf-1 content in Ec-hESC, might ensure their restricted migration by preserving the contracted cellular phenotype. In conclusion, our findings suggest that cellular levels of Raf-1 adjust the threshold of hESC migration in endometriosis.     

Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor

We have examined the interaction between the serine/threonine kinase proto-oncogene product Raf-1 and the tyrosine kinase PDGF beta-receptor. Raf-1 tyrosine phosphorylation and kinase activity were increased by PDGF treatment of 3T3 cells or CHO cells expressing wild-type PDGF receptors but not mutant receptors defective in transmitting mitogenic signals, suggesting that the increase in Raf-1 kinase activity is a significant event in PDGF-induced mitogenesis. Concurrent with these increases, Raf-1 associated with the ligand-activated PDGF receptor. Furthermore, both mammalian Raf-1 and Raf-1 expressed using a recombinant baculoviral vector, associated in vitro with baculoviral-expressed PDGF receptor. This association was markedly decreased by prior phosphatase treatment of the receptor. Following incubation of partially purified baculoviral-expressed PDGF receptor with partially purified Raf-1, Raf-1 became phosphorylated on tyrosine and its serine/threonine kinase activity increased 4- to 6-fold. This is the first demonstration of the direct modulation of a protein activity by a growth factor receptor tyrosine kinase.